A detailed history of Envestnet Asset Management Inc transactions in Sanofi stock. As of the latest transaction made, Envestnet Asset Management Inc holds 3,090,019 shares of SNY stock, worth $147 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,090,019
Previous 3,252,326 4.99%
Holding current value
$147 Million
Previous $158 Million 12.91%
% of portfolio
0.06%
Previous 0.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$48.54 - $58.53 $7.88 Million - $9.5 Million
-162,307 Reduced 4.99%
3,090,019 $178 Million
Q2 2024

Aug 08, 2024

BUY
$45.39 - $50.36 $11.2 Million - $12.4 Million
246,224 Added 8.19%
3,252,326 $158 Million
Q1 2024

May 13, 2024

BUY
$45.75 - $52.48 $18.1 Million - $20.8 Million
395,995 Added 15.17%
3,006,102 $146 Million
Q4 2023

Feb 13, 2024

SELL
$43.13 - $54.79 $9.87 Million - $12.5 Million
-228,796 Reduced 8.06%
2,610,107 $130 Million
Q3 2023

Nov 13, 2023

BUY
$50.95 - $55.2 $33.2 Million - $36 Million
651,756 Added 29.8%
2,838,903 $152 Million
Q2 2023

Aug 04, 2023

SELL
$50.45 - $57.18 $180 Million - $204 Million
-3,560,045 Reduced 61.94%
2,187,147 $118 Million
Q1 2023

May 11, 2023

BUY
$45.86 - $54.45 $200 Million - $238 Million
4,364,665 Added 315.7%
5,747,192 $313 Million
Q4 2022

Feb 07, 2023

BUY
$38.86 - $48.55 $4.79 Million - $5.98 Million
123,228 Added 9.79%
1,382,527 $67 Million
Q3 2022

Nov 10, 2022

BUY
$37.22 - $100.5 $2.58 Million - $6.97 Million
69,342 Added 5.83%
1,259,299 $47.9 Million
Q2 2022

Aug 03, 2022

BUY
$48.99 - $57.46 $4.88 Million - $5.72 Million
99,616 Added 9.14%
1,189,957 $59.5 Million
Q1 2022

May 04, 2022

BUY
$48.48 - $53.65 $9.59 Million - $10.6 Million
197,740 Added 22.15%
1,090,341 $56 Million
Q4 2021

Feb 04, 2022

BUY
$47.07 - $52.35 $6.58 Million - $7.32 Million
139,773 Added 18.57%
892,601 $44.7 Million
Q3 2021

Oct 07, 2021

BUY
$47.89 - $53.12 $5.89 Million - $6.53 Million
122,919 Added 19.51%
752,828 $36.3 Million
Q2 2021

Aug 04, 2021

BUY
$49.36 - $54.25 $2.57 Million - $2.83 Million
52,141 Added 9.02%
629,909 $33.2 Million
Q1 2021

May 04, 2021

BUY
$45.46 - $50.51 $2.18 Million - $2.42 Million
47,880 Added 9.04%
577,768 $28.6 Million
Q4 2020

Feb 02, 2021

SELL
$45.3 - $51.62 $612,954 - $698,470
-13,531 Reduced 2.49%
529,888 $25.7 Million
Q3 2020

Oct 09, 2020

BUY
$49.47 - $53.77 $800,424 - $869,998
16,180 Added 3.07%
543,419 $27.3 Million
Q2 2020

Jul 08, 2020

BUY
$42.91 - $52.5 $225,105 - $275,415
5,246 Added 1.0%
527,239 $26.9 Million
Q1 2020

Apr 23, 2020

BUY
$38.02 - $51.66 $2.44 Million - $3.32 Million
64,221 Added 14.03%
521,993 $22.8 Million
Q4 2019

Feb 11, 2020

BUY
$44.25 - $50.86 $3.76 Million - $4.33 Million
85,080 Added 22.83%
457,772 $23 Million
Q3 2019

Oct 17, 2019

BUY
$40.34 - $46.64 $1.61 Million - $1.87 Million
39,996 Added 12.02%
372,692 $17.3 Million
Q2 2019

Aug 02, 2019

BUY
$40.43 - $44.3 $2.4 Million - $2.63 Million
59,301 Added 21.69%
332,696 $14.4 Million
Q1 2019

May 10, 2019

BUY
$40.83 - $45.43 $1.87 Million - $2.08 Million
45,838 Added 20.14%
273,395 $12.1 Million
Q4 2018

Feb 13, 2019

BUY
$41.48 - $45.59 $9.44 Million - $10.4 Million
227,557 New
227,557 $9.88 Million
Q3 2018

Nov 14, 2018

SELL
$40.0 - $44.84 $5.14 Million - $5.76 Million
-128,492 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$37.63 - $41.22 $85,683 - $93,857
2,277 Added 1.8%
128,492 $5.14 Million
Q1 2018

May 09, 2018

SELL
$38.98 - $45.76 $6.05 Million - $7.1 Million
-155,153 Reduced 55.14%
126,215 $5.05 Million
Q4 2017

Feb 20, 2018

SELL
$42.86 - $50.61 $3.39 Million - $4 Million
-79,068 Reduced 21.94%
281,368 $12.1 Million
Q3 2017

Nov 13, 2017

SELL
$47.04 - $50.34 $4.01 Million - $4.29 Million
-85,154 Reduced 19.11%
360,436 $17.9 Million
Q2 2017

Aug 14, 2017

BUY
N/A
445,590
445,590 $21.4 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $120B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.